• 370 Citations
20012024
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Gary E Schiltz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Ligands Medicine & Life Sciences
HIV Protease Inhibitors Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels Chemical Compounds
Protease Inhibitors Chemical Compounds
Scaffolds Chemical Compounds
Assays Chemical Compounds
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2011 2024

Neuropharmacology
Pharmaceutical Preparations
Ligands
Technology
Neurobiology
Kidney
Kidney Diseases
Research Personnel
Therapeutics
Nanomedicine
Antidepressive Agents
High-Throughput Screening Assays
Manuscripts
Organized Financing
Research
CXC Chemokines
MAP Kinase Signaling System
Chemokine Receptors
Chemokines
Prostatic Neoplasms

Research Output 2001 2019

  • 370 Citations
  • 21 Article
  • 2 Review article
  • 1 Chapter

Development of Tetrahydroindazole-Based Potent and Selective Sigma-2 Receptor Ligands

Iyamu, I. D., Lv, W., Malik, N., Mishra, R. K. & Schiltz, G. E., Jul 3 2019, In : ChemMedChem. 14, 13, p. 1248-1256 9 p.

Research output: Contribution to journalArticle

Drug Discovery
Ligands
Central Nervous System Diseases
Neurology
Solubility
2 Citations (Scopus)

Discovery of a novel class of potent and selective tetrahydroindazole-based sigma-1 receptor ligands

Iyamu, I. D., Lv, W., Malik, N., Mishra, R. K. & Schiltz, G. E., May 1 2019, In : Bioorganic and Medicinal Chemistry. 27, 9, p. 1824-1835 12 p.

Research output: Contribution to journalArticle

Protein Transport
Ligands
Molecular modeling
Central Nervous System Diseases
Structure-Activity Relationship
Fluorine
Palladium
Bioactivity
Biological Products
Scaffolds
1 Citation (Scopus)

Regulation of MLL/COMPASS stability through its proteolytic cleavage by taspase1 as a possible approach for clinical therapy of leukemia

Zhao, Z., Wang, L., Volk, A. G., Birch, N. W., Stoltz, K. L., Bartom, E. T., Marshall, S. A., Rendleman, E. J., Nestler, C. M., Shilati, J., Schiltz, G. E., Crispino, J. D. & Shilatifard, A., Jan 1 2019, In : Genes and Development. 33, 1-2, p. 61-74 14 p.

Research output: Contribution to journalArticle

Aspartate Ammonia-Lyase
Threonine
Leukemia
Casein Kinase II
Therapeutics

Small molecules target the interaction between tissue transglutaminase and fibronectin

Sima, L. E., Yakubov, B., Zhang, S., Condello, S., Grigorescu, A. A., Nwani, N. G., Chen, L., Schiltz, G. E., Arvanitis, C., Zhang, Z. Y. & Matei, D. E., Jan 1 2019, In : Molecular cancer therapeutics. 18, 6, p. 1057-1068 12 p.

Research output: Contribution to journalArticle

Fibronectins
Ovarian Neoplasms
Cell-Matrix Junctions
Interferometry
Focal Adhesion Protein-Tyrosine Kinases